Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Developed Markets
  • Asset Class: Equity
  • Geographic Focus: Global

Capital Group Global Equity Fnd

+ Add to Watchlist

CAPCR4U:LX

25.35 USD 0.01 0.04%

As of 12:55:46 ET on 03/03/2015.

Snapshot for Capital Group Global Equity Fnd (CAPCR4U)

Year To Date: +3.68% 3-Month: +2.14% 3-Year: +13.09% 52-Week Range: 22.72 - 25.36
1-Month: +3.98% 1-Year: +6.92% 5-Year: +10.29% Beta vs M1WO: 0.99

Mutual Fund Chart for CAPCR4U

No chart data available.
  • CAPCR4U:LX 25.35
  • 1M
  • 1Y
Interactive CAPCR4U Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CAPCR4U

Capital Group Global Equity Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long term growth through investment primarily in listed Equity, researched and selected on a world-wide basis.

Inception Date: 07-07-2008 Telephone: 352-46-2685-611
Managers: NILLY SILKORSKY / RUDOLF STAEHELIN
Web Site: www.thecapitalgroup.com

Fundamentals for CAPCR4U

NAV (on 2015-03-03) 25.35
Assets (M) (on 2015-03-03) 855.26
Fund Leveraged N
Minimum Investment 25,000,000.00
Minimum Subsequent Investment -

Dividends for CAPCR4U

No dividends reported

Fees & Expenses for CAPCR4U

Front Load 5.25
Back Load -
Current Mgmt Fee 0.70
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CAPCR4U

Filing Date: 12/31/2014
Name Position Value % of Total
Goldman Sachs Group Inc/The 167,100 26,946,858 2.975%
Gilead Sciences Inc 278,620 22,192,011 2.450%
Roche Holding AG 82,049 18,418,034 2.034%
Novo Nordisk A/S 524,527 18,334,103 2.024%
Chevron Corp 192,822 17,785,966 1.964%
Pernod Ricard SA 170,670 15,746,014 1.738%
Incyte Corp 243,631 14,845,138 1.639%
Unilever NV 436,109 14,234,598 1.572%
ASML Holding NV 153,370 13,726,615 1.516%
AIA Group Ltd 2,970,600 13,626,676 1.504%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil